Kathy Gratton
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
-
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
- PARP inhibition in cancer therapy
Papers in
-
- Protein Degradation and Inhibitors 2
- Oncology 9
- PARP inhibition in cancer therapy 4
- CAR-T cell therapy research 3
- Co-authors
- Nizar J. Bahlis (13 shared papers)Paola Neri (12 shared papers)Douglas A. Stewart (12 shared papers)Peter Duggan (10 shared papers)Adnan Mansoor (6 shared papers)Alexander C. Klimowicz (3 shared papers)Li Ren (5 shared papers)Lawrence Boise (2 shared papers)
- Journals
- Blood (13 papers)Cancers (1 paper)Clinical Cancer Research (1 paper)The American Journal of Human Genetics (1 paper)The Journal of Immunology (1 paper)
- Partner nations
- CanadaUnited StatesItaly
In The Last Decade
Kathy Gratton
22 papers receiving 414 citations
Peers
Comparison fields: 5 of 58
- Hematology 167
- Oncology 167
- Molecular Biology 296
- Genetics 83
- Immunology 55
Countries citing papers authored by Kathy Gratton
This map shows the geographic impact of Kathy Gratton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy Gratton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy Gratton more than expected).
Fields of papers citing papers by Kathy Gratton
This network shows the impact of papers produced by Kathy Gratton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy Gratton. The network helps show where Kathy Gratton may publish in the future.
Co-authors
The 25 scholars most cited alongside Kathy Gratton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 127 | |
| 2 | 2011 | 121 | |
| 3 | 2018 | 43 | |
| 4 | 2016 | 31 | |
| 5 | 1998 | 30 | |
| 6 | 2019 | 20 | |
| 7 | 2012 | 9 | |
| 8 | 1997 | 7 | |
| 9 | 2009 | 7 | |
| 10 | 2013 | 5 | |
| 11 | 2011 | 4 | |
| 12 | 2011 | 3 | |
| 13 | 2012 | 3 | |
| 14 | 2015 | 2 | |
| 15 | 2013 | 2 | |
| 16 | 2016 | 2 | |
| 17 | Development of a YAC contig covering the minimal region of a CSNB1 locus in Xp11 | 1994 | 1 |
| 18 | 2007 | 1 | |
| 19 | 2009 | 1 | |
| 20 | 2012 | 1 |
About Kathy Gratton
Kathy Gratton is a scholar working on Molecular Biology, Oncology, Hematology, Genetics and Biotechnology, having authored 23 papers that have together received 423 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (6 papers), Virus-based gene therapy research (5 papers), Cancer Research and Treatments (4 papers), PARP inhibition in cancer therapy (4 papers), Cell Adhesion Molecules Research (3 papers), CAR-T cell therapy research (3 papers), MicroRNA in disease regulation (2 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Hematology (167 citations), Oncology (167 citations), Molecular Biology (296 citations), Genetics (83 citations) and Immunology (55 citations). Kathy Gratton has collaborated with scholars based in Canada, United States and Italy. Frequent co-authors include Nizar J. Bahlis, Paola Neri, Douglas A. Stewart, Peter Duggan, Adnan Mansoor, Alexander C. Klimowicz, Li Ren, Lawrence Boise, Pierfrancesco Tassone and Satbir Thakur. Their work appears in journals such as Blood, Cancers, Clinical Cancer Research, The American Journal of Human Genetics and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.